Scholar Rock Holding Corp (SRRK)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$46.94

+1.44 (+3.16%)

Market Cap: $5.54B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

44%(15/34)

Avg Surprise

-90.65%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.84

Range$-0.94 - $-0.73

12 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.85+1.0%

60d ago$-0.83-2.1%

30d ago$-0.84-1.0%

7d ago$-0.84-0.6%

Current$-0.84

Revenue Consensus

$283670

Range$0 - $4M

15 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.75

Range$-1.14 - $0.29

12 analysts

Revenue Consensus

$5M

Range$1M - $12M

16 analysts

Last 12 of 35 reported quarters and 2 upcoming estimates

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.75	$-1.14 - $0.29	-	-	12	-	-
Sep 30, 2026Sep 26EST	-	$-0.84	$-0.94 - $-0.73	-	-	12	1 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 6, 2026Reported Aug 6	$-0.84	$-0.84	$-0.94 - $-0.77	+0.00%	Beat	11	3 3 30d	+14.3%
Mar 31, 2026Mar 26 Reported May 7, 2026Reported May 7	$-0.83	$-0.78	$-0.91 - $-0.62	-6.41%	Miss	13	1 0 30d	-23.9%
Dec 31, 2025Dec 25 Reported Mar 3, 2026Reported Mar 3	$-0.88	$-0.90	$-1.07 - $-0.57	+2.04%	Beat	11	2 7 30d	-44.3%
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$-0.90	$-0.84	$-1.00 - $-0.57	-7.14%	Miss	9	0 1 30d	-36.4%
Jun 30, 2025Jun 25 Reported Aug 6, 2025Reported Aug 6	$-0.98	$-0.67	$-0.73 - $-0.57	-46.27%	Miss	5	No revisions (30d)	-63.3%
Mar 31, 2025Mar 25 Reported May 14, 2025Reported May 14	$-0.67	$-0.71	$-0.93 - $-0.54	+5.63%	Beat	4	0 3 30d	-13.6%
Dec 31, 2024Dec 24 Reported Feb 27, 2025Reported Feb 27	$-0.61	$-0.63	$-0.67 - $-0.58	+2.99%	Beat	5	1 4 30d	-22.0%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.66	$-0.59	$-0.65 - $-0.54	-11.86%	Miss	9	No revisions (30d)	-24.5%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.60	$-0.59	$-0.72 - $-0.57	-1.69%	Miss	9	No revisions (30d)	-27.7%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$-0.59	$-0.51	$-0.60 - $-0.45	-15.69%	Miss	9	No revisions (30d)	-20.4%
Dec 31, 2023Dec 23 Reported Mar 19, 2024Reported Mar 19	$-0.50	$-0.49	$-0.54 - $-0.45	-2.04%	Miss	8	No revisions (30d)	-8.7%
Sep 30, 2023Sep 23 Reported Nov 7, 2023Reported Nov 7	$-0.53	$-0.51	$-0.68 - $-0.46	-3.92%	Miss	8	1 0 30d	+3.6%

Key Metrics

Valuation
P/E Ratio	-13.61	EV/EBITDA	N/A
Price/FCF	-20.64x	FCF Yield	-4.84%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-167.80%	ROIC	-71.59%
Financial Health
Debt/Equity	0.77x	Interest Coverage	-38.15x
Current Ratio	7.02x	Quick Ratio	7.02x
Trading Statistics
Beta	0.79	Avg Volume	1.68M
52-Week High	$61.76	52-Week Low	$28.79

Technical Indicators Dashboard

Moving Averages

SMA 10$44.09

SMA 20$42.58

SMA 50$47.13

SMA 200$48.18

EMA 10$44.47

EMA 20$44.07

EMA 50$46.03

EMA 200$46.67

MACD

Line: -0.12Signal: -0.98Hist: 0.87

ADX

ADX: 24.0+DI: 26.1-DI: 13.7

Aroon & PSAR

Aroon Up100.0

Aroon Down40.0

PSAR$42.27

Bollinger Bands

Upper Band$46.70

Lower Band$38.46

%B Position1935%(Upper)

Band Width1.03

RSI (14-Day)

Neutral

59.7

Momentum Oscillators

Stoch %K89.4

Stoch %D85.7

Williams %R-12.7

ROC (10d)13.1%

Momentum5.45

CCI (20d)172.5

MFI (14d)75.0

Volatility Measures

ATR (14d)$2.05(4.4%)

StdDev (20d)2.06

Hist Vol38.2%(Moderate)

Volume Flow

VWAP$46.63

OBV13.2M

AD Line27.2M

CMF (20d)0.177

Volume Metrics

Avg Vol (20d)1.6M

Vol Ratio1.3x

VWMA (20d)$42.55

Pivot Points

R3$48.52

R2$47.26

R1$46.38

Pivot Point$45.12

S1$44.24

S2$42.98

S3$42.10

Advanced Oscillators

TSI-2.34

Ultimate Osc57.1

KST-46.36

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$11.66M	$0
Cost of Revenue	$0	$0	$425,000	$0	$0	$0	$395,000	$0	$0	$0	$672,000	$0
Gross Profit	$0	$0	$-425,000	$0	$0	$0	$-395,000	$0	$0	$0	$-672,000	$0

Operating Expenses	$108.90M	$102.02M	$91.90M	$103.55M	$112.11M	$77.09M	$69.36M	$64.78M	$59.50M	$58.42M	$48.03M	$43.67M
R&D	$58.23M	$51.81M	$46.88M	$50.49M	$62.40M	$48.68M	$50.36M	$48.72M	$42.37M	$43.09M	$34.96M	$30.34M
SG&A	$50.67M	$50.20M	$45.02M	$53.06M	$49.71M	$28.41M	$18.99M	$16.06M	$17.13M	$15.32M	$13.07M	$13.34M
Operating Income	$-108,901,000	$-102,016,000	$-91,896,000	$-103,550,000	$-112,109,000	$-77,090,000	$-69,357,000	$-64,780,000	$-59,498,000	$-58,419,000	$-48,032,000	$-43,672,000

Interest Income	$4.09M	$2.94M	$0	$2.73M	$3.41M	$4.23M	$0	$2.08M	$2.72M	$0	$0	$0
Interest Expense	$4.52M	$2.30M	$0	$1.33M	$1.21M	$1.82M	$0	$1.74M	$1.72M	$0	$0	$0
Income Before Tax	$-109,896,000	$-102,173,000	$-88,598,000	$-102,220,000	$-110,031,000	$-74,723,000	$-64,888,000	$-64,479,000	$-58,508,000	$-58,419,000	$-48,032,000	$-43,672,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-109,896,000	$-105,510,000	$-90,965,000	$-102,220,000	$-110,031,000	$-74,723,000	$-66,454,000	$-64,479,000	$-58,508,000	$-56,853,000	$-46,126,000	$-42,359,000

EBITDA	$-109,201,000	$-102,606,000	$-91,571,000	$-103,828,000	$-111,904,000	$-76,957,000	$-70,261,000	$-65,010,000	$-60,273,000	$-59,663,000	$-49,104,000	$-48,418,000
EBIT	$-109,471,000	$-102,806,000	$-91,896,000	$-103,619,000	$-112,236,000	$-77,134,000	$-69,357,000	$-64,818,000	$-59,512,000	$-58,419,000	$-48,032,000	$-43,672,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about SRRK

News

Will ISEMBLYD Launch Change Scholar Rock Stock Narrative

Scholar Rock Holding is advancing the commercialization of ISEMBLYD for spinal muscular atrophy, with plans for a 50-country rollout...

Simply Wall St•Nov 5, 2026 4:38 AM ET11/5/26•Somewhat-Bullish

Scholar Rock Holding (SRRK) Stock Price, Chart & Analysis

This article provides an analysis of Scholar Rock Holding (SRRK) stock, including its latest price of $43.98 as of November 3, 2026...

www.debelegger.nl•Nov 3, 2026 7:42 PM ET11/3/26•Neutral

Srinivas Akkaraju Acquires 289,470 Shares of Scholar Rock (SRRK) Between October 23-26, 2026

Director Srinivas Akkaraju, through affiliated investment funds, purchased 289,470 shares of Scholar Rock Holding Corp (SRRK) common stock between October 23 and October 26...

Kalkine Media•Oct 27, 2026 9:14 PM ET10/27/26•Bullish

Scholar Rock director Akkaraju buys $12 million in shares By Investing.com

Srinivas Akkaraju, a director at Scholar Rock Holding Corp, acquired approximately $12 million worth of common stock between October 23 and October 26, 2026...

Investing.com South Africa•Oct 27, 2026 8:14 PM ET10/27/26•Somewhat-Bullish

Form 4 Scholar Rock Holding Corp: Srinivas Akkaraju (Director) For: 23 October

This article reports on a Form 4 filing for Scholar Rock Holding Corp, specifically detailing a transaction by Director Srinivas Akkaraju on October 23rd. The filing indicates insider trading activity...

Investing.com Nigeria•Oct 27, 2026 8:14 PM ET10/27/26•Neutral

SRRK Valuation and Fair Value

P/E: -13.6x
P/FCF: -20.6x
P/B: 24.2x

See GNG's fair value

SRRK Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: -71.6%
ROE: -167.8%
FCF yield: -4.8%

SRRK Competitors

Company	Ticker
Waystar Holding Corp. Common Stock	WAY
PTC Therapeutics Inc	PTCT
Haemonetics Corporation	HAE
Concentra Group Holdings Parent, Inc.	CON
Kodiak Sciences Inc	KOD
Merit Medical Systems Inc	MMSI
CG Oncology, Inc. Common stock	CGON
GRAIL, LLC	GRAL

Sector: Healthcare

SRRK Analyst Ratings

Consensus: Buy
Analysts: 18
Strong Buy: 2
Buy: 15
Hold: 1
Sell: 0
Strong Sell: 0

SRRK Bull Case vs Bear Case

Bull case

94.4% of SRRK's analyst ratings are Buy or Strong Buy.

Bear case

SRRK beat EPS estimates in 37.5% of its last 8 reported quarters.
SRRK's quarterly revenue changed -100.0% year over year.

SRRK Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -7.6%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.84
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 1 up, 0 down

SRRK Earnings Date

SRRK reports Nov 10, 2026, before the open. The date is confirmed.

SRRK Earnings Call

The latest SRRK earnings call transcript on file is labeled 2026Q2.

Read the 2026Q2 transcript

SRRK ETF Holders

GNG tracks 16 ETFs that hold SRRK. The largest weights:

State Street SPDR S&P Biotech ETF (XBI), 0.77% of the fund
iShares Biotechnology ETF (IBB), 0.29% of the fund
Fidelity Growth Company K6 Fund (FGKFX), 0.22% of the fund
Fidelity Growth Company Fund (FDGRX), 0.21% of the fund
BlackRock Health Sciences Trust (BME), 0.18% of the fund

Open the ETF Stock Exposure tool for SRRK

See insider activity

Frequently Asked Questions About SRRK

When does SRRK report earnings?

Scholar Rock Holding Corp (SRRK) is confirmed to report earnings on Nov 10, 2026.

Does SRRK pay dividends?

Scholar Rock Holding Corp (SRRK) does not currently pay a regular dividend.

What is SRRK's market cap?

Scholar Rock Holding Corp (SRRK) has a market capitalization of $5.54B with a current stock price of $46.94.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In